Pages
Products
RFP Lentivirus

RFP Lentivirus

Cat.No. :  LV00949Z

Titer: ≥1*10^7 TU/mL / ≥1*10^8 TU/mL / ≥1*10^9 TU/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Lentivirus Particle Information

Quality Control

Cat. No. LV00949Z
Description This lentivirus contains RFP reporter gene under CMV promoter and puromycin resistance gene under PGK promoter. 
Target Gene RFP
Titer Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

First-generation lentiviral vectors contain a large portion of the HIV genome, including the gag and pol genes, as well as some additional viral proteins. The first-generation lentiviral vectors were also designed to include an envelope protein from another virus, most commonly VSV-G. VSV-G recognizes a ubiquitously expressed receptor that has recently been identified as the low-density lipoprotein (LDL) receptor, which enables lentiviral vectors to transduce a wide variety of cells. The VSV-G gene is encoded on a plasmid separate from the other lentiviral genes. First-generation lentiviral vectors contain the lentiviral helper genes vif, vpr, vpu, and nef, as well as the regulatory genes tat and rev. vif, vpr, vpu, and nef provide a survival/fitness advantage for lentivirus replication in vivo, but they are not essential for viral growth in vitro; tat and rev are required for viral replication. Subsequently, safer second-generation lentiviral vectors were developed that lack the additional virulence factors vif, vpr, vpu, and nef. Removal of these additional genes does not inhibit the transfer of genetic material to host cells. Third-generation lentiviral vectors further improve safety by separating the viral genome into separate plasmids, making the generation of recombinant viruses even less likely. In third-generation systems, the gag and pol genes are encoded on separate plasmids from the rev or env genes, resulting in a vector consisting of three separate plasmids containing the viral sequences required for packaging. The tat gene was removed in third-generation lentiviral vectors because it has unnecessary functions when a constitutively active promoter is introduced into the upstream long terminal repeat (LTR) of the transgene construct. Introducing deletions in the 3'LTR of the viral genome to create self-inactivating (SIN) lentiviral vectors can disrupt the promoter/enhancer activity of the LTR, further improving safety.

Astrocytes are a highly heterogeneous population of glial cells that are important regulators of brain development and homeostasis. The heterogeneity of the astrocyte population underlies its functional diversity. In addition to the typical mammalian astrocyte architecture, the human cerebral cortex exhibits a radial distribution of interlaminar astrocytes in the supragranular layer. These primate-specific interlaminar astrocytes are located in the superficial layers and project long processes that traverse multiple layers of the cerebral cortex. However, their functional properties and their role in regulating neural circuits remain unclear due to the lack of available experimental models. Here, researchers modeled human interlaminar astrocytes in humanized glial chimeric mice by transplanting astrocytes differentiated from human induced pluripotent stem cells into the mouse cortex. This model provides a new platform for understanding neuron-glial interactions and their alterations in neurological diseases.

Here, researchers differentiated human induced pluripotent stem cells (hiPSCs) into neural progenitor cells (NPCs) and subsequently into astrocytes via a xeno-free, chemically defined approach (Figure 1a). To visualize hiPSC-astroglia in chimeric mouse brains, researchers generated RFP-expressing astrocytes by transducing NPCs with lentivirus expressing RFP in astrocyte differentiation medium (Figure 1a). Prior to implantation, RFP-expressing hiPSC-astroglia showed robust expression of canonical markers, including aldehyde dehydrogenase 1 family member L1 (ALDH1L1), glial fibrillary acidic protein (GFAP), and S100 calcium-binding protein B (S100B) (Figure 1b). RFP-expressing hiPSC-derived immature astrocytes were transplanted into the cortex of postnatal day 1 (P1) rag1−/− immunodeficient mouse brains. Two-site injection resulted in the widespread distribution of RFP-expressing hiPSC-astrocytes in the frontal cortex. Although thick bands of cell bodies were found in the superficial layers of the cortex at the site where the hiPSC-astroglia were likely engrafted, more distally, the cells were primarily confined to layer 1. Furthermore, although cells with interlaminar processes were found in the superficial layers, protoplasmic astrocytes were observed in the deeper layers of the putative injection site.

Figure 1. Generation of hiPSC-astrocytes. (Padmashri R, et al., 2021)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High titer

Creative Biogene's RFP Lentivirus is a reliable product. The high titer lentivirus ensured that we consistently achieved high levels of transgene expression in our cell cultures.

United Kingdom

12/02/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER